Preparations for submission of a Biologics License Application (BLA) for Cylembio® (imsapepimut and etimupepimut, adjuvanted) to FDA by year end 2025 remain on track. The trial completed enrollment in ...

Special Judge Jitendra Singh directed the Investigation Officer (IO) to verify the medical documents filed by the counsel for Barkha Singh seeking exemption on medical grounds. The counsel submitted ...

Altera Corporation unveiled its latest programmable solutions tailored for embedded developers who are pushing the boundaries ...

Q4 2024 Earnings Call Transcript March 10, 2025 Operator: Welcome to BioNTech’s Fourth Quarter and Full-Year 2024 Earnings ...

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today highlights key scientific contributions in 2024-2025 that are shaping the future of cancer immunotherapy.

The Trump administration is still trying to convince Americans that tariffs will save the economy, even as the stock market ...

Altera is launching its latest family of Agilex FPGA chips to help developers expand the boundaries of the intelligent edge.

Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ETCompany ParticipantsZack Armen - Head of Investor Relations, ...

Agilex 5 E-Series FPGAs, with AI-infused fabric, bring high levels of integration and improved computing capabilities for intelligent edge applications, including video, industrial, robotics, and ...